New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling
Chem Res Toxicol. 2026 Mar 30. doi: 10.1021/acs.chemrestox.5c00468. Online ahead of print. ABSTRACT Craniofacial abnormalities account for roughly one-third of all congenital birth defects worldwide.… Read More »New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling